Impact of joint hypermobility syndrome on gastric accommodation and nutrient tolerance in functional dyspepsia.
Ehlers-Danlos syndrome type III
functional dyspepsia
gastric accommodation
joint hypermobility syndrome
nutrient tolerance
Journal
Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
25
11
2020
received:
16
10
2020
accepted:
06
01
2021
pubmed:
3
2
2021
medline:
19
1
2022
entrez:
2
2
2021
Statut:
ppublish
Résumé
Functional dyspepsia (FD) is defined as the presence of gastroduodenal symptoms in the absence of organic disease that is likely to explain the symptoms. Joint hypermobility (JH) refers to the increased passive or active movement of a joint beyond its normal range and is characteristically present in patients with joint hypermobility syndrome (JHS), which is a hypermobile subtype of Ehlers-Danlos syndrome (EDS). Recent reports have highlighted the co-existence of FD with Ehlers-Danlos syndrome. Our aim was to study the prevalence of JHS in FD compared with healthy subjects and to study the impact of co-existing JHS on gastric motility, nutrient tolerance, and dyspeptic symptoms in FD. FD patients filled out a dyspepsia symptom severity score. Intragastric pressure (IGP) was measured with high-resolution manometry (HRM) during the intragastric infusion of nutrition drink (ND, 1.5 Kcal/ml, 60 ml/min) until maximal satiation in healthy subjects and FD. We compared IGP profiles and nutrient tolerance in HS and FD with or without JHS. JHS was present in 54% of FD patients (n = 39, 41.2 ± 2.2 years old) and 7% of healthy subjects (n = 15, 27.3 ± 2.3 years old). IGP drop and nutrient tolerance were lower in non-JHS-FD compared with JHS-FD and HS (AUC JHS-FD: -17.9 ± 2.5 vs. non-JHS-FD: -13.0 ± 3.3 mmHg min, p = 0.2, HS:-19.6 ± 2.9 mmHg min; ND tolerance non-JHS-FD: 671.0 ± 96.0 vs. JHS-FD: 842.7 ± 105.7 Kcal, p = 0.25, HS: 980.0 ± 108.1 Kcal). JHS often co-exists with FD. Non-JHS-FD was characterized by decreased accommodation and lower nutrient tolerance characterized compared with JHS-FD. Clinicaltrials.gov, reference number NCT04279990.
Banques de données
ClinicalTrials.gov
['NCT04279990']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14086Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466-1479.PubMed PMID: 16678560. eng.
Lacy BE, Weiser KT, Kennedy AT, Crowell MD, Talley NJ. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013;38(2):170-177.PubMed PMID: 23725230. eng.
El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003;18(4):387-393.PubMed PMID: 12940923. eng.
Tack J, Drossman DA. What's new in Rome IV? Neurogastroenterol Motil. 2017;29(9). PubMed PMID: 28303651. Epub 2017/03/17. eng.1-5.
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262-1279.
Tack J, Talley NJ. Functional dyspepsia-symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol. 2013;10(3):134-141.PubMed PMID: 23399526. eng.
Fikree A, Aktar R, Grahame R, et al. Functional gastrointestinal disorders are associated with the joint hypermobility syndrome in secondary care: a case-control study. Neurogastroenterol Motil. 2015;27(4):569-579.PubMed PMID: 25817057. eng.
Castori M, Morlino S, Pascolini G, Blundo C, Grammatico P. Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet. 2015;169C(1):54-75.PubMed PMID: 25821092. eng.
Farmer AD, Fikree A, Aziz Q. Addressing the confounding role of joint hypermobility syndrome and gastrointestinal involvement in postural orthostatic tachycardia syndrome. Clin Auton Res. 2014;24(3):157-158.PubMed PMID: 24682800. eng.
Fikree A, Grahame R, Aktar R, et al. A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2014;12(10):1680-1687e2.PubMed PMID: 24440216. eng.
Fikree A, Aziz Q, Grahame R. Joint hypermobility syndrome. Rheum Dis Clin North Am. 2013;39(2):419-430.PubMed PMID: 23597972. eng.
Fikree A, O’Brien C, Kuo P, Bravi I, Sifrim D, Aziz Q. Gastroparesis in the joint hypermobility syndrome. Neurogastroenterol Motil. 2012;24:S2.
Fikree A, Jafari J, Grahame R, Sifrim D. Dysphagia in patients with the joint hypermobility syndrome. Gut. 2011;60:A181.
Zarate N, Farmer AD, Grahame R, et al. Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? Neurogastroenterol Motil. 2010;22(3):252-e78. PubMed PMID: 19840271. eng.
Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8-26.PubMed PMID: 28306229. eng.
Tinkle B, Castori M, Berglund B, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017;175(1):48-69.PubMed PMID: 28145611. Epub 2017/02/01. eng.
Levy HP. Ehlers-Danlos Syndrome, Hypermobility Type. Seattle (WA): University of Washington, Seattle; 1993-2015. [Internet]. GeneReviews®; 2004. http://www.ncbi.nlm.nih.gov/books/NBK1279/
Castori M, Camerota F, Celletti C, et al. Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: a pilot study on 21 patients. Am J Med Genet A. 2010;152A(3):556-564.PubMed PMID: 20140961. eng.
Zeitoun JD, Lefèvre JH, de Parades V, et al. Functional digestive symptoms and quality of life in patients with Ehlers-Danlos syndromes: results of a national cohort study on 134 patients. PLoS One. 2013;8(11):e80321. PubMed PMID: 24278273. PMCID: PMC3838387. eng.
Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R. Postural tachycardia syndrome-current experience and concepts. Nat Rev Neurol. 2011;8(1):22-34.PubMed PMID: 22143364. Epub 2011/12/06. eng.
Lam CY, Palsson OS, Whitehead WE, et al. Rome IV functional gastrointestinal disorders and health impairment in subjects with hypermobility spectrum disorders or hypermobile Ehlers-Danlos syndrome. Clin Gastroenterol Hepatol. 2020;19(2):277-287.
Remvig L, Jensen DV, Ward RC. Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature. J Rheumatol. 2007;34(4):804-809.PubMed PMID: 17407233. Epub 2007/01/15. eng.
Remvig L, Engelbert RH, Berglund B, et al. Need for a consensus on the methods by which to measure joint mobility and the definition of norms for hypermobility that reflect age, gender and ethnic-dependent variation: is revision of criteria for joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type indicated? Rheumatology (Oxford). 2011;50(6):1169-1171.PubMed PMID: 21482540. Epub 2011/04/10. eng.
Juul-Kristensen B, Røgind H, Jensen DV, Remvig L. Inter-examiner reproducibility of tests and criteria for generalized joint hypermobility and benign joint hypermobility syndrome. Rheumatology (Oxford). 2007;46(12):1835-1841.PubMed PMID: 18006569. Epub 2007/11/15. eng.
Rotondo A, Janssen P, Mulè F, Tack J. Effect of the GLP-1 analog liraglutide on satiation and gastric sensorimotor function during nutrient-drink ingestion. Int J Obes (Lond). 2013;37(5):693-698.PubMed PMID: 22846777. eng.
Janssen P, Verschueren S, Ly HG, Vos R, Van Oudenhove L, Tack J. Intragastric pressure during food intake: a physiological and minimally invasive method to assess gastric accommodation. Neurogastroenterol Motil. 2011;23(4):316-322, e153-4. PubMed PMID: 21299720. eng.
Carbone F, Tack J. The effect of sildenafil on gastric motility and satiation in healthy controls. United European Gastroenterol J. 2018;6(6):846-854.PubMed PMID: 30023062. PMCID: PMC6047290. Epub 2018/03/30. eng.
Carbone F, Tack J, Hoffman I. The intragastric pressure measurement: a novel method to assess gastric accommodation in functional dyspepsia children. J Pediatr Gastroenterol Nutr. 2017;64(6):918-924.PubMed PMID: 27557427. eng.
Carbone F, Vanuytsel T, Tack J. The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects. Neurogastroenterol Motil. 2017;29(12). PubMed PMID: 28695632. Epub 2017/07/11. eng. https://doi.org/10.1111/nmo.13146
Carbone F, Goelen L, Porters N, et al. Impaired gastric distribution of a meal is associated with impaired intragastric pressure measurement and satiation in FD. Gastroenterology, 2016;150(4):S1-S1271.
Masuy I, Carbone F, Holvoet L, Vandenberghe A, Vanuytsel T, Tack J. The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: the first study in a Belgian functional dyspepsia population. Neurogastroenterol Motil. 2019;32(2):e13739.
Papathanasopoulos A, Rotondo A, Janssen P, et al. Effect of acute peppermint oil administration on gastric sensorimotor function and nutrient tolerance in health. Neurogastroenterol Motil. 2013;25(4):e263-e271.PubMed PMID: 23489975. eng.
Azpiroz F, Malagelada JR. Pressure activity patterns in the canine proximal stomach: response to distension. Am J Physiol. 1984;247(3 Pt 1):G265-G272.PubMed PMID: 6476116. eng.
Janssen P, Verschueren S, Tack J. Intragastric pressure as a determinant of food intake. Neurogastroenterol Motil. 2012;24(7):612-625, e267-8. PubMed PMID: 22519421. eng.
Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. 2003;115(1):33-40.PubMed PMID: 12867232. eng.
Tack J, Caenepeel P, Piessevaux H, Cuomo R, Janssens J. Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut. 2003;52(9):1271-1277.PubMed PMID: 12912857. PMCID: PMC1773806. eng.
Janssen JP, Tack JF. Intragastric Pressure (IGP) during intragastric nutrient drink infusion: a method to objectively discriminate functional dyspeptic (FD) patients with impaired nutrient tolerance and/or gastric accommodation. Gastroenterology. 2011;104(5):S1-S1062.
Kindt S, Tack J. Impaired gastric accommodation and its role in dyspepsia. Gut. 2006;55(12):1685-1691.PubMed PMID: 16854999. PMCID: PMC1856470. eng.
Tack J, Demedts I, Meulemans A, Schuurkes J, Janssens J. Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans. Gut. 2002;51(2):219-224.PubMed PMID: 12117883. PMCID: PMC1773301. eng.
Farré R, Vicario M. Abnormal barrier function in gastrointestinal disorders. Handb Exp Pharmacol. 2017;239:193-217.PubMed PMID: 27995392. eng.
Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63(2):262-271.PubMed PMID: 23474421. eng.
Aktar R, Peiris M, Fikree A, et al. A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function. J Physiol. 2019;597(6):1503-1515.PubMed PMID: 30605228. PMCID: PMC6418764. Epub 2019/01/23. eng.
Aktar R, Peiris M, Fikree A, et al. The extracellular matrix glycoprotein tenascin-X regulates peripheral sensory and motor neurones. J Physiol. 2018;596(17):4237-4251.PubMed PMID: 29917237. PMCID: PMC6117562. Epub 2018/07/18. eng.
Zweers MC, Hakim AJ, Grahame R, Schalkwijk J. Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects. Arthritis Rheum. 2004;50(9):2742-2749.PubMed PMID: 15457441. eng.
Kindt S, Coulie B, Wajs E, Janssens J, Tack J. Reproducibility and symptomatic predictors of a slow nutrient drinking test in health and in functional dyspepsia. Neurogastroenterol Motil. 2008;20(4):320-329.PubMed PMID: 18371010. eng.